CTOs on the Move

UP Health System – Marquette

www.mgh.org

 
Marquette General Health System is a Marquette, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.mgh.org
  • 580 W. College Ave.
    Marquette, MI USA 49855
  • Phone: 906.228.9440

Executives

Name Title Contact Details

Similar Companies

Wellington Parc Of Owensboro

Wellington Parc Of Owensboro is a Owensboro, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Summus Global

Summus Global, the leading virtual specialist platform, empowers families by providing access to a network of 4,000+ top specialists across 48 leading hospitals -- within days, from anywhere in the world.

SouthLight Healthcare

SouthLight Healthcare is a nonprofit organization that provides outpatient and community-based services for mental health and substance use treatment. They empower the journey through prevention, education, and innovative treatment solutions delivered ...

RealAge

RealAge is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kymera Therapeutics

Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.